Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
MERK’s net profit slipped 48.4% due to high costs of sales
16 Aug 2024 18:33
PT Merck Tbk (MERK), a pharmaceutical company under Merck Holding GmbH from Germany, booked net profit of IDR 47.2 billion in the first half (H1) of 2024.
Indofarma still on loss streak until H1 2024
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
Acquiring Probiotec, PYFA’s subsidiary receives IDR 1.07 trillion
12 Jun 2024 09:25
PYFA Australia Pty Ltd (PAPL), an entity under PT Pyridam Farma Tbk (PYFA), has secured extra capital of USD 99.57 million or equal to approximately IDR 1.07 trillion.
Kimia Farma's loss worsened 6 times in 2023
03 Jun 2024 08:41
PT Kimia Farma Tbk (KAEF), a state-owned pharmaceutical company through PT Bio Farma (Persero), reported worsening loss in 2023, down to IDR 1.48 trillion.
PYFA granted approval from shareholders to offer 16 billion shares in rights issue
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.